Kevzara (sarilumab) may be used in combination with methotrexate for moderately to severely active disease, in patients intolerant to one or more disease-modifying anti-rheumatic drugs.
In addition to tocilizumab, sarilumab, another IL-6 receptor blocker, has also been evaluated for its effectiveness in patients experiencing relapses during glucocorticoid tapering. A recent study ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback